Skip Nav Destination
Issues
1 July 2016
-
Cover Image
Cover Image
Loss of HNRNP E1-dependent regulation of CDC27 translation leads to constitutive CDC27 expression, resulting in mitotic aberrations and aneuploidy in NMuMG cells. Confocal immunofluorescence microscopy was performed on fixed, asynchronous NMuMG cells constitutively expressing CDC27 (NMuMG-CDC27) using anti-alpha tubulin, anti-HNRNP E1, and DAPI to visualize mitoses. Mitotic aberrations were observed in NMuMG-CDC27 cells, while parental control cells exhibited normal mitoses, suggesting that cell cycle–dependent regulation of CDC27 expression is important in maintaining genomic integrity. For more information, see the article by Link and colleagues beginning on page 634. - PDF Icon PDF LinkTable of Contents
ISSN 1541-7786
EISSN 1557-3125
Molecular Cancer Research
Table of Contents
Highlights
Review
Cell Death and Survival
HuR Contributes to TRAIL Resistance by Restricting Death Receptor 4 Expression in Pancreatic Cancer Cells
Carmella Romeo; Matthew C. Weber; Mahsa Zarei; Danielle DeCicco; Saswati N. Chand; Angie D. Lobo; Jordan M. Winter; Janet A. Sawicki; Jonathan N. Sachs; Nicole Meisner-Kober; Charles J. Yeo; Rajanikanth Vadigepalli; Mark L. Tykocinski; Jonathan R. Brody
DNA Damage and Repair
Genomics
Expression of ANRIL–Polycomb Complexes–CDKN2A/B/ARF Genes in Breast Tumors: Identification of a Two-Gene (EZH2/CBX7) Signature with Independent Prognostic Value
Didier Meseure; Sophie Vacher; Kinan Drak Alsibai; Andre Nicolas; Walid Chemlali; Martial Caly; Rosette Lidereau; Eric Pasmant; Celine Callens; Ivan Bieche
Oncogenes and Tumor Suppressors
Signal Transduction
Journal Archive
Molecular Cancer Research
(2002-Present; volumes 1-current)Published monthly since November, 2002.
(ISSN 0008-5472)
Cell Growth & Differentiation
(1990-2002; volumes 1-13)Published monthly 1990- September, 2002.
(ISSN 1044-9523)
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.